Skip to main content
TipRanks
Go Ultimate75% OFF

Sinopharm Group Co (X2S1) Stock Statistics & Valuation Metrics

1 Followers

Total Valuation

Sinopharm Group Co has a market cap or net worth of EUR 6.05B. The enterprise value is EUR 23.42B.

Market Cap
EUR 6.05B
Enterprise Value
EUR 23.42B

Share Statistics

Sinopharm Group Co has 268,362,150 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
268,362,150
Owned by Insiders
―
Owned by Institutions
<0.01%

Financial Efficiency

Sinopharm Group Co’s return on equity (ROE) is 0.08 and return on invested capital (ROIC) is 5.69%.

Return on Equity (ROE)
0.08
Return on Assets (ROA)
0.02
Return on Invested Capital (ROIC)
5.69%
Return on Capital Employed (ROCE)
0.11
Revenue Per Employee
5.90M
Profits Per Employee
73.33K
Employee Count
94,910
Asset Turnover
1.43
Inventory Turnover
8.19

Valuation Ratios

The current PE Ratio of Sinopharm Group Co is 6.30. Sinopharm Group Co’s PEG ratio is 1.96.

PE Ratio
6.30
PS Ratio
0.08
PB Ratio
0.52
Price to FCF
2.37
Price to Operating Cash Flow
2.19
PEG Ratio
1.96

Income Statement

In the last 12 months, Sinopharm Group Co had revenue of 559.50B and earned 6.96B in profits. Earnings per share was 11.10.

Revenue
559.50B
Gross Profit
40.09B
Operating Income
16.21B
Pretax Income
14.40B
Net Income
6.96B
EBITDA
20.50B
Earnings Per Share (EPS)
11.10

Cash Flow

In the last 12 months, operating cash flow was 22.20B and capital expenditures -1.53B, giving a free cash flow of 20.67B billion.

Operating Cash Flow
22.20B
Free Cash Flow
20.67B
Free Cash Flow per Share
29.95

Dividends & Yields

Sinopharm Group Co pays an annual dividend of ―, resulting in a dividend yield of 4.55%

Dividend Per Share
―
Dividend Yield
4.55%
Payout Ratio
N/A
Free Cash Flow Yield
42.24%
Earnings Yield
15.92%

Stock Price Statistics

Beta
0.33
52-Week Price Change
-19.07%
50-Day Moving Average
8.65
200-Day Moving Average
9.54
Relative Strength Index (RSI)
67.59
Average Volume (3m)
80

Important Dates

Sinopharm Group Co upcoming earnings date is Mar 19, 2027, TBA (Not Confirmed).

Last Earnings Date
Oct 25, 2026
Next Earnings Date
Mar 19, 2027
Ex-Dividend Date
―

Financial Position

Sinopharm Group Co as a current ratio of 1.41, with Debt / Equity ratio of 129.33%

Current Ratio
1.41
Quick Ratio
1.15
Debt to Market Cap
1.24
Net Debt to EBITDA
2.29
Interest Coverage Ratio
6.68

Taxes

In the past 12 months, Sinopharm Group Co has paid 3.86B in taxes.

Income Tax
3.86B
Effective Tax Rate
0.27

Enterprise Valuation

Sinopharm Group Co EV to EBITDA ratio is 3.85, with an EV/FCF ratio of 4.48.

EV to Sales
0.15
EV to EBITDA
3.85
EV to Free Cash Flow
4.48
EV to Operating Cash Flow
4.15

Balance Sheet

Sinopharm Group Co has EUR 41.90B in cash and marketable securities with EUR 81.32B in debt, giving a net cash position of -EUR 39.42B billion.

Cash & Marketable Securities
EUR 41.90B
Total Debt
EUR 81.32B
Net Cash
-EUR 39.42B
Net Cash Per Share
-EUR 146.88
Tangible Book Value Per Share
EUR 205.74

Margins

Gross margin is 7.03%, with operating margin of 2.95%, and net profit margin of 1.24%.

Gross Margin
7.03%
Operating Margin
2.95%
Pretax Margin
2.54%
Net Profit Margin
1.24%
EBITDA Margin
3.83%
EBIT Margin
3.11%

Analyst Forecast

The average price target for Sinopharm Group Co is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target
―
Price Target Upside
―
Analyst Consensus
―
Analyst Count
―
Revenue Growth Forecast
-4.46%
EPS Growth Forecast
0.14%

Scores

Smart Score
3
AI Score
―